Stock Comparison
RDY vs TEVA
Dr. Reddy’s Laboratories Ltd ADR and Teva Pharma Industries Ltd ADR side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$12.81B
$38.67B
P/E (TTM)
28.5
24.8
Forward P/E
28.5
16.0
Price/Sales
0.0
2.2
Price/Book
3.2
4.7
EV/EBITDA
14.1
16.3
Dividend Yield
0.54%
—
Profitability
Net Margin
12.80%
9.02%
Operating Margin
1.54%
19.20%
Return on Equity
11.80%
21.60%
Return on Assets
5.74%
6.38%
Growth (YoY)
Revenue Growth
-11.60%
2.30%
Earnings Growth
-86.20%
72.20%
Price & Risk
Beta
0.3
0.9
52-Week High
$15.67
$37.35
52-Week Low
$12.19
$14.99
Analyst Target
$14.31
$40.90
Compare RDY and TEVA your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.